NCT00544154View on ClinicalTrials.gov

Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

CDP870

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY